Symbol | Exchange | Currency |
|---|
United Therapeutics (UTHR) reported Q3 EPS of $4.91, $0.85 better than the analyst estimate of $4.06. Revenue for the quarter came in at $516 million versus the consensus estimate...
Investing.com - United Therapeutics (NASDAQ:UTHR) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. United...
The COVID-19 pandemic highlighted the importance of health care and the role biopharma companies play in drug and vaccine development. As a result, the sector grew tremendously...
United Therapeutics (NASDAQ:UTHR) UTHR announced that the FDA has issued a complete response letter to its new drug application (“NDA”) for its drug device combination...
United Therapeutics (NASDAQ:UTHR) UTHR announced that the FDA has issued a complete response letter to its new drug application (“NDA”) for its drug device combination...
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat ulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin), which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). It also includes technologies designed supply of transplantable organs and tissues and improves outcomes for transplant recipients through regenerative medicine, three-dimensional (3-D) organ bioprinting, xenotransplantation and ex-vivo lung perfusion.
| Average | 285.50 (+8.05% Upside) |
| High | 375.00 |
| Low | 150.00 |
| Price | 264.23 |
| No. of Analysts | 12 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
| Technical Indicators | Sell | Strong Buy | Strong Buy | Buy | Strong Buy |
| Summary | Neutral | Strong Buy | Strong Buy | Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 143.96 | 144.25 | 141.90 | +2.10 | +1.48% | 53.60M | NASDAQ | |||
| 160.27 | 161.42 | 154.76 | +15.84 | +10.97% | 232.88M | NASDAQ | |||
| 99.22 | 99.49 | 96.92 | +2.04 | +2.10% | 67.87M | NASDAQ | |||
| 224.71 | 227.08 | 223.67 | -0.19 | -0.08% | 6.72M | NYSE | |||
| 75.17 | 77.08 | 74.28 | +0.26 | +0.35% | 48.24M | NASDAQ | |||
| 97.52 | 97.57 | 95.38 | +2.30 | +2.42% | 30.02M | NASDAQ | |||
| 30.09 | 30.11 | 29.33 | +0.39 | +1.31% | 46.35M | NASDAQ | |||
| 198.02 | 201.66 | 192.78 | +4.79 | +2.48% | 48.45M | NASDAQ | |||
| 7.88 | 7.945 | 7.77 | +0.050 | +0.64% | 6.28M | NYSE | |||
| 48.34 | 48.47 | 47.83 | +0.36 | +0.75% | 12.94M | NASDAQ | |||
| 2.47 | 2.50 | 2.46 | -0.030 | -1.20% | 36.81K | NYSE | |||
| 106.87 | 108.55 | 105.82 | -1.72 | -1.58% | 9.66M | NYSE | |||
| 42.59 | 42.75 | 41.56 | +0.92 | +2.21% | 209.24K | NASDAQ | |||
| 44.25 | 44.30 | 43.61 | -0.41 | -0.92% | 38.36M | NYSE | |||
| 248.00 | 248.31 | 242.00 | +7.39 | +3.07% | 33.13M | NASDAQ |